Market Newsdesk

CHICAGO, April 23, 2026 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that it will release its results for the first quarter 2026 on Thursday, May 7, 2026.

Management will host a webcast and conference call on May 7, 2026, at 10:00 a.m. ET to discuss the results and provide a business update. The conference call will be available via public webcast through the Public Shareholders section of GCM Grosvenor’s website at
www.gcmgrosvenor.com/public-shareholders and a replay will be available on the website soon after the call’s completion for at least seven (7) days.

To register for the call, visit www.gcmgrosvenor.com/public-shareholders.

About GCM Grosvenor

GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management solutions provider with approximately $91 billion in assets under management across private equity, infrastructure, real estate, credit, and absolute return investment strategies. The firm has specialized in alternatives for more than 50 years and is dedicated to delivering value for clients by leveraging its cross-asset class and flexible investment platform. 

GCM Grosvenor’s experienced team of approximately 550 professionals serves a global client base of institutional and individual investors. The firm is headquartered in Chicago, with offices in New York, Toronto, London, Frankfurt, Tokyo, Hong Kong, Seoul and Sydney. For more information, visit: gcmgrosvenor.com.

Source: GCM Grosvenor

Public Shareholders Contact

Stacie Selinger
[email protected]
312-506-6583

Media Contact

Abigail Ruck
H/Advisors Abernathy
[email protected]
212-371-5999

RICHMOND, Va., April 23, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced that the Company will host a conference call on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2026.

ARKO Corp.’s management team will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call.

Date: Thursday, May 7, 2026
Time: 9:00 a.m. Eastern Time
Toll-free dial-in number: (877) 605-1792
International dial-in number: (201) 689-8728
Webcast: ARKO’s Q1 2026 Earnings Call

A telephonic replay will be available approximately three hours after the call concludes through Sunday, June 7, 2026.

Toll-free replay number: (877) 660-6853
International replay number: (201) 612-7415
Replay ID: 13760314

A link to the live webcast and replay will also be available at https://www.arkocorp.com/news-events/ir-calendar. We encourage all participants to register at least 15 minutes prior to the 9:00 a.m. ET start time. If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About ARKO Corp.
ARKO Corp. (Nasdaq: ARKO) is a Fortune 500 company that is one of the largest operators of convenience stores and wholesalers of fuel in the United States. Based in Richmond, VA, our retail segment operates retail convenience stores under more than 25 regional store brands in the District of Columbia and more than 30 states across the Mid-Atlantic, Midwestern, Northeastern, Southeastern and Southwestern U.S. Our highly recognizable Family of Community Brands offers delicious, prepared foods, beer, snacks, candy, hot and cold beverages, and multiple popular quick serve restaurant brands. Our wholesale segment supplies fuel to independent dealers and consignment agents; our fleet fueling segment includes the operation of proprietary and third-party cardlock locations (unstaffed fueling locations), and commissions from the sales of fuel using proprietary fuel cards that provide customers access to a nationwide network of fueling sites; and our GPM Petroleum segment primarily engages in inter-segment transactions related to the wholesale distribution of fuel to substantially all of our sites that sell fuel in the retail, wholesale and fleet fueling segments. In February 2026, we completed the initial public offering of our subsidiary ARKO Petroleum Corp., which is the primary operating entity for the wholesale, fleet fueling, and GPMP segments. To learn more about GPM stores, visit: www.gpminvestments.com. To learn more about ARKO, visit: www.arkocorp.com. To learn more about APC visit: https://www.arkopetroleum.com/.

Media Contact

Jordan Mann
ARKO Corp.
ARKO Petroleum Corp.
[email protected]

Investor Contact
Sean Mansouri, CFA
Elevate IR
(720) 330-2829
[email protected]

PLANTATION, Fla., April 23, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and omnichannel fulfillment partner to the entertainment and pop culture collectibles industry, supplying more than 340,000 unique SKUs across music, video, video games, licensed merchandise, and exclusive collectibles to over 35,000 retail and e-commerce storefronts, played a central role in the success of this year’s Record Store Day, shipping more than 700,000 units to over 1,500 independent music retailers across the United States—an increase of nearly 8% compared to Record Store Day 2025—during what was the largest Record Store Day release slate to date.

For the first time in Record Store Day’s history, more than one million units were pressed for the event, reflecting continued growth in consumer demand for vinyl and significantly increased complexity across the physical music supply chain. Alliance’s ability to support retailers at this scale highlights the company’s operational depth and readiness for high-volume, time-sensitive releases.

Record Store Day (RSD) is an annual global celebration of independent record stores, artists, and the culture surrounding music retail. Founded in 2008, the event brings together retailers, labels, distributors, and artists to offer exclusive releases and in-store experiences that drive traffic, sales, and community engagement.

Against the backdrop of a record-setting production year, Alliance Entertainment’s distribution facility delivered strong performance in the weeks leading up to Record Store Day, ensuring stores received product well in advance of the event. This execution enabled retailers to prepare confidently for the busiest weekend of the year and focus on delivering a strong in-store experience for customers.

This year’s Record Store Day generated strong sales across the country. Top-selling artists included Taylor Swift, Laufey, Olivia Dean, Jeff Buckley, and Pink Floyd, reflecting a mix of contemporary artists, emerging favorites, and iconic catalog titles that drove demand across multiple consumer segments.

Alliance’s owned distribution arm, AMPED, marked a milestone performance during Record Store Day 2026. AMPED supported more than 120 exclusive Record Store Day titles, representing nearly 30% of the total RSD offering, the largest number of exclusives the company has ever distributed for the event. Notable top sellers from AMPED-distributed releases included Jerry Garcia and the John Coltrane Quartet, underscoring strong demand for curated jazz and classic catalog exclusives.

“This was an exceptional Record Store Day for stores, artists, and fans,” said Michael Kurtz, Co-Founder of Record Store Day. “With more vinyl and CDs than ever before, execution mattered. Alliance Entertainment played a key role in helping stores get the inventory they needed, when they needed it, to make the day successful.”

“Record Store Day is the most important weekend of the year for independent retail,” said Ken Glaser, Senior Vice President of Sales at Alliance Entertainment. “Shipping over 700,000 units during a year when the industry surpassed one million pressed units for the event reflects our scale and operational focus. The independent retail community is fundamental to our business, and our continued growth with this channel speaks to our commitment to invest more resources, infrastructure, and support—both for Record Store Day and throughout the year.”

“After decades in music retail, we’ve never seen a Record Store Day like this. The sales were unprecedented, and that level of success only happens when you have complete confidence in your distribution partner. Alliance delivered the product, on time and in perfect condition, and that made all the difference,” said Karl Groeger, Owner of Looney Tunes, West Babylon, NY.

Scott Farrell, Co-Owner, Down In The Valley, Minneapolis, MN, added, “Record Store Day continues to raise the bar, and this year was our most successful ever, driven by incredible customer turnout and energy across our stores. Alliance Entertainment played an important supporting role in making the day run smoothly, and a nice surprise was the Handmade by Robots releases—both Ozzy Osbourne and Hello Kitty sold out completely, with customers still asking for more.”

Alliance Entertainment continues to grow alongside independent retailers by expanding its logistics capabilities, inventory depth, exclusive programs, and dedicated account support. The company remains focused on strengthening the ecosystem that enables independent music retail to thrive.

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 325,000 unique in-stock SKUs — including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games — Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. The company’s growing collectibles portfolio includes Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises. Leveraging decades of operational expertise, exclusive licensing partnerships, and a capital-light, scalable infrastructure, Alliance is a trusted partner to the world’s top entertainment brands and retailers. Our omnichannel platform connects collectors and fans to the products, franchises, and experiences they love — across formats and generations. For more information, visit www.aent.com.

Forward-Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance.

These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; our ability to continue as a going concern absent access to sources of liquidity; risks and failure by Alliance to meet the covenant requirements of its revolving credit facility, including a fixed charge coverage ratio; risks that a breach of the revolving credit facility, including Alliance’s recent breach of the covenant requirements, could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; risk that the COVID-19 pandemic, and local, state, and federal responses to addressing the pandemic may have an adverse effect on our business operations, as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
[email protected]

PARAMUS, NJ, April 23, 2026 (GLOBE NEWSWIRE) — Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage disorders (LSDs), today announced its participation in the National Tay-Sachs & Allied Diseases Association (NTSAD) Annual Family Conference, taking place April 30 through May 3, 2026, at the Hyatt Regency in Reston, Virginia.

“The NTSAD Annual Family Conference is an important opportunity to connect directly with the families and advocates at the heart of the rare disease community,” said Alex Yang, J.D., LL.M., Chief Executive Officer of Polaryx Therapeutics. “These interactions are invaluable as we advance PLX-200 in a meaningful Phase 2 basket trial and our broader pipeline with the goal of delivering disease-modifying therapies for patients with significant unmet need.”

The NTSAD Annual Family Conference is a leading gathering of patients, caregivers, clinicians, and researchers dedicated to advancing care and treatment for individuals affected by Tay-Sachs, Sandhoff disease, and related disorders. Polaryx will engage directly with the patient and advocacy community, share updates on its clinical development programs, and reinforce its commitment to advancing therapies for underserved pediatric populations.

Polaryx’s lead program, PLX-200, is an oral small molecule designed to target multiple underlying disease mechanisms across several LSDs, including Sandhoff disease, and is being advanced through the SOTERIA Phase 2 basket trial evaluating multiple indications. Polaryx believes that active engagement with the patient community is critical to informing clinical development and accelerating the delivery of meaningful treatment options.

About Tay-Sachs and Sandhoff Disease

Tay-Sachs and Sandhoff diseases are part of a group of inherited disorders called GM2 gangliosidoses, resulting from deficiencies in the hexosaminidase enzyme. This mutation leads to an accumulation of GM2 ganglioside in nerve cells, resulting in rapid neurodegeneration. While the prevalence of Tay-Sachs disease is approximately one in 100,000 births, Sandhoff disease is much rarer with a prevalence of approximately 0.67 per 100,000 births. We believe that there are approximately 1,200 Sandhoff disease patients in the United States, Europe and select regions of the ROW. There is currently no established standard of care for these diseases.

About the SOTERIA Trial

SOTERIA is a Phase 2, open-label, single arm trial intended to assess the safety, tolerability, and clinical activity of Polaryx’s lead drug candidate, PLX-200, in CLN2, CLN3, Krabbe disease, and Sandhoff disease, four different LSDs whose patient populations Polaryx believes represent approximately one quarter of the LSD population. SOTERIA is designed to be flexible, resource-efficient, and provide important data and information important to PLX-200’s future clinical development. Polaryx received a safe to proceed letter in October 2025 from the FDA and plans to initiate SOTERIA in the second half of 2026 in trial sites in the United States as well as in Europe and Asia or other foreign jurisdictions. Designed with a high degree of flexibility, SOTERIA represents a resource-efficient opportunity to validate PLX-200’s preclinical science across multiple LSDs while gathering data that will be invaluable in planning PLX-200’s future development pathway, including the initiation of potentially pivotal trials. For the CLN2 and CLN3 cohorts, although the entire trial is open label, these cohorts will incorporate analyses comparing natural history data as a control arm to PLX-200’s treated arm. A natural history study is a preplanned observational study intended to track the course of the disease. Should the data demonstrate compelling clinical activity, Polaryx may seek conditional marketing authorization.

About Polaryx Therapeutics

Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing patient-friendly small molecule and gene therapy treatments for rare orphan lysosomal storage disorders (LSDs). Founded in 2014, Polaryx seeks to deliver safe, effective, and patient-friendly treatments that address the underlying pathophysiology of these catastrophic diseases and their significant unmet need. Our approach integrates small molecule therapies, including a combination therapy, and a gene therapy, positioning us to potentially address both the genetic and downstream pathological features of LSDs. Our small molecule drug candidates share similar modes of action that have been demonstrated to address lysosomal dysfunction, neuroinflammation, and neuronal loss in our validated animal models that closely mimic human clinical phenotypes. Our most advanced product candidate, PLX-200, targets several LSDs and we intend to launch SOTERIA, a Phase 2 basket trial, to evaluate PLX-200’s safety and efficacy. For more information, please visit www.polaryx.com.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, statements regarding: Polaryx’s clinical development plans for PLX-200, including the timing for initiation of the SOTERIA trial. Words such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “design,” “estimate,” “predict,” “potential,” “develop,” “plan” or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While Polaryx believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to the company on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Polaryx’s filings with the U.S. Securities and Exchange Commission (the SEC), many of which are beyond the company’s control and subject to change. Actual results could be materially different. Risks and uncertainties include: global macroeconomic conditions and related volatility, expectations regarding the initiation, progress, and expected results of Polaryx’s clinical trials; expectations regarding the timing, completion and outcome of Polaryx’s clinical trials; the timing or likelihood of regulatory filings and approvals; liquidity and capital resources; and other risks and uncertainties identified in Polaryx’s most recently filed Form 10-K with the SEC and subsequent disclosure documents Polaryx may file with the SEC. Polaryx claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. Polaryx expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.

Media Contact:

CORE IR
(212) 655-0924
[email protected]

Investor Contact:

CORE IR
(212) 655-0924
[email protected]

FAIRFIELD, N.J., April 23, 2026 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended March 31, 2026 of $10.1 million, or $0.16 per diluted share, compared to $9.4 million, or $0.15 per diluted share, for the quarter ended December 31, 2025.

The Company also announced that its Board of Directors has declared a quarterly cash dividend of $0.11 per share, payable on May 20, 2026, to stockholders of record as of May 6, 2026.

Craig L. Montanaro, President and Chief Executive Officer, commented, “We are pleased to report continued momentum in our core earnings this quarter, highlighted by our sixth consecutive quarter of net interest margin expansion. Quarter-over-quarter, net interest margin increased seven basis points as net interest income grew 3%. These results reflect the ongoing favorable repricing and remixing of our loan portfolio which, along with improving funding dynamics, positions us well for continued earnings momentum in the periods ahead.”

Mr. Montanaro continued, “During the quarter, we made strategic investments to strengthen our deposit franchise. We expanded our Corporate Banking team with the addition of four high-powered deposit-focused relationship officers who will accelerate our growth in relationship‑based middle-market commercial deposits. In parallel, we formed a new Specialty Deposits team specifically focused on select high-value deposit verticals in order to further diversify our funding sources.”

Mr. Montanaro concluded, “Our partnership with The Lab Consulting, a management consulting firm engaged to support process improvement and operational efficiency initiatives, is now well underway, and we are encouraged by the early momentum of this initiative. The opportunities identified to streamline processes, enhance automation, and improve the client experience support our commitment to operational excellence and scalable growth. Collectively, these actions position us well to continue delivering sustainable earnings improvement and long‑term shareholder value.”

Third Quarter Highlights

• Pre-tax, pre-provision net revenue increased 5.5% to $13.0 million, or $0.21 per diluted share, reflecting ongoing strengthening of core earnings.
• Net interest margin expanded by seven basis points to 2.21%, extending the momentum of margin improvement for the sixth consecutive quarter.
• Continued advancing the loan portfolio diversification strategy by growing commercial business, construction, and home equity loans by 18.5%, 14.3% and 4.0%, respectively, while strategically reducing multifamily mortgage exposure.
• Tangible book value per share improved $0.09, or 0.9%, to $10.02.

Balance Sheet

• Total assets were $7.61 billion at March 31, 2026, a decrease of $13.2 million, or 0.2%, from December 31, 2025.
• Investment securities totaled $1.09 billion at March 31, 2026, a decrease of $19.3 million, or 1.7%, from December 31, 2025.
• Loans receivable totaled $5.78 billion at March 31, 2026, an increase of $25.8 million, or 0.4%, from December 31, 2025, primarily reflecting increases in commercial and industrial (“C&I”) and construction loans, partially offset by a decrease in multifamily mortgage loans, which reflects our ongoing strategic remix of the portfolio.
• Deposits were $5.73 billion at March 31, 2026, an increase of $17.5 million, or 0.3%, from December 31, 2025.
• Borrowings were $1.06 billion at March 31, 2026, a decrease of $35.0 million, or 3.2%, from December 31, 2025, reflecting reductions in overnight borrowings, partially offset by an increase in Federal Home Loan Bank (“FHLB”) advances.
• At March 31, 2026, the Company maintained available secured borrowing capacity with the FHLB and the Federal Reserve Discount Window of $2.45 billion, representing 32.2% of total assets.

Earnings

Net Interest Income and Net Interest Margin

• Net interest margin expanded by seven basis points to 2.21% for the quarter ended March 31, 2026. The increase for the quarter was primarily driven by lower costs and average balances on interest-bearing liabilities, partially offset by lower average yields on interest-earning assets.
• For the quarter ended March 31, 2026, net interest income increased $1.3 million to $39.2 million from $38.0 million for the quarter ended December 31, 2025. Included in net interest income for the quarters ended March 31, 2026 and December 31, 2025, respectively, was purchase accounting accretion of $552,000 and $494,000, and loan prepayment penalty income of $422,000 and $544,000.

Non-Interest Income

• For the quarter ended March 31, 2026, non-interest income increased $523,000, or 9.4%, to $6.1 million from $5.6 million for the quarter ended December 31, 2025, primarily driven by a non-recurring pre-tax gain of $1.0 million on the sale of properties held for sale in the current period.
• Fees and service charges decreased $373,000, or 28.8%, to $922,000 for the quarter ended March 31, 2026 from $1.3 million for the quarter ended December 31, 2025. The decrease was primarily driven by the absence of $245,000 in loan related fee income associated with the payoff of a single construction loan recorded in the prior period.
• Electronic banking fees and charges decreased $84,000, or 17.8%, to $389,000 for the quarter ended March 31, 2026 from $473,000 for the quarter ended December 31, 2025, primarily driven by lower income from interchange fees.

Non-Interest Expense

• For the quarter ended March 31, 2026, non-interest expense increased $1.1 million, or 3.6%, to $32.3 million from $31.2 million for the quarter ended December 31, 2025, primarily driven by increases in salary and benefits, net occupancy, and advertising, partially offset by decreases in other expense.
• Salary and benefits expense increased $943,000 to $19.3 million for the quarter ended March 31, 2026 from $18.4 million for the quarter ended December 31, 2025, primarily driven by an increase in payroll taxes and employee benefits associated with the start of a new calendar year and a non-recurring severance charge of $205,000 recorded in the current period.
• Net occupancy expense of premises increased $375,000 to $3.3 million for the quarter ended March 31, 2026 from $2.9 million for the quarter ended December 31, 2025, driven by seasonally higher snow removal expenses of $527,000 recorded in the current period.
• Advertising and marketing expense increased $253,000 to $665,000 for the quarter ended March 31, 2026 from $412,000 for the quarter ended December 31, 2025, primarily driven by higher advertising expenses across various formats.
• Other expense decreased $377,000 to $3.5 million for the quarter March 31, 2026 from $3.8 million for the quarter ended December 31, 2025, primarily driven by the absence of non-recurring professional fees incurred in the prior period associated with the Company’s partnership with The Lab Consulting and a decline in fraud losses in the current period. Changes in the other components of non-interest expense between comparative periods reflected normal operating fluctuations within those line items.

Income Taxes

• Income tax expense totaled $2.5 million for the quarter ended March 31, 2026 compared to $2.3 million for the quarter ended December 31, 2025, resulting in an effective tax rate of 19.8% in each respective period.

Asset Quality

• The balance of non-performing assets increased $1.1 million to $52.4 million, or 0.69% of total assets, at March 31, 2026 from $51.3 million, or 0.67% of total assets, at December 31, 2025.
• Net charge-offs totaled $626,000, or 0.04% of average loans, on an annualized basis, for the quarter ended March 31, 2026, compared to $669,000, or 0.05% of average loans, on an annualized basis, for the quarter ended December 31, 2025.
• For the quarter ended March 31, 2026, the Company recorded a provision for credit losses of $391,000, compared to $567,000 for the quarter ended December 31, 2025. The provision for credit loss expense for the quarter ended March 31, 2026 was primarily due to loan growth and charge-offs associated with certain individually evaluated loans, partially offset by quantitative risk factor adjustments.
• Allowance for credit losses (“ACL”) was $44.7 million, or 0.77% of total loans, at March 31, 2026, a decrease of $235,000 from $45.0 million, or 0.78% of total loans, at December 31, 2025. The decrease in the ACL from December 31, 2025 was primarily driven by loan charge-offs, partially offset by a provision for credit losses, as noted above.

Capital

• For the quarter ended March 31, 2026, book value per share increased $0.09, or 0.8%, to $11.79 while tangible book value per share increased $0.09, or 0.9%, to $10.02.
• At March 31, 2026, total stockholders’ equity included after-tax net unrealized losses on securities available for sale of $68.7 million, partially offset by after-tax unrealized gains on derivatives of $2.7 million. After-tax net unrecognized losses on securities held to maturity of $8.2 million were not reflected in total stockholders’ equity.
• At March 31, 2026, the Company’s tangible equity to tangible assets ratio equaled 8.65%. Additionally, the regulatory capital ratios of both the Company and the Bank continued to be in excess of all applicable regulatory requirements as of March 31, 2026.

This earnings release should be read in conjunction with Kearny Financial Corp.’s Q3 2026 Investor Presentation, a copy of which is available through the Investor Relations link located at the bottom of the page of our website at www.kearnybank.com and via a Current Report on Form 8-K on the website of the Securities and Exchange Commission at www.sec.gov.

Statements contained in this news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, factors discussed in documents filed by the Company with the Securities and Exchange Commission from time to time. The Company does not undertake and specifically disclaims any obligation to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Category: Earnings

Linked-Quarter Comparative Financial Analysis

Kearny Financial Corp. Consolidated Balance Sheets (Unaudited)
(Dollars and Shares in Thousands, Except Per Share Data)		March 31, 2026			December 31, 2025			Variance or Change			Variance or Change Pct.
Assets
Cash and cash equivalents		$	123,836		$	147,340		$	(23,504	)	-16.0	%
Securities available for sale			983,325			1,000,397			(17,072	)	-1.7	%
Securities held to maturity			110,581			112,800			(2,219	)	-2.0	%
Loans held-for-sale			12,183			8,786			3,397		38.7	%
Loans receivable			5,779,181			5,753,393			25,788		0.4	%
Less: allowance for credit losses on loans			(44,723	)		(44,958	)		(235	)	-0.5	%
Net loans receivable			5,734,458			5,708,435			26,023		0.5	%
Premises and equipment			41,896			42,559			(663	)	-1.6	%
Federal Home Loan Bank stock			55,737			57,212			(1,475	)	-2.6	%
Accrued interest receivable			28,304			27,420			884		3.2	%
Goodwill			113,525			113,525			—		—	%
Core deposit intangible			1,080			1,198			(118	)	-9.8	%
Bank owned life insurance			312,050			309,404			2,646		0.9	%
Deferred income taxes, net			50,961			51,617			(656	)	-1.3	%
Other assets			39,720			40,185			(465	)	-1.2	%
Total assets		$	7,607,656		$	7,620,878		$	(13,222	)	-0.2	%
Liabilities
Deposits:
Non-interest-bearing		$	631,506		$	627,180		$	4,326		0.7	%
Interest-bearing			5,097,576			5,084,370			13,206		0.3	%
Total deposits			5,729,082			5,711,550			17,532		0.3	%
Borrowings			1,060,000			1,095,000			(35,000	)	-3.2	%
Advance payments by borrowers for taxes			19,317			18,474			843		4.6	%
Other liabilities			36,225			38,458			(2,233	)	-5.8	%
Total liabilities			6,844,624			6,863,482			(18,858	)	-0.3	%
Stockholders’ Equity
Common stock			648			648			—		—	%
Paid-in capital			495,442			494,959			483		0.1	%
Retained earnings			349,881			346,749			3,132		0.9	%
Unearned ESOP shares			(17,511	)		(17,997	)		486		2.7	%
Accumulated other comprehensive loss			(65,428	)		(66,963	)		1,535		2.3	%
Total stockholders’ equity			763,032			757,396			5,636		0.7	%
Total liabilities and stockholders’ equity		$	7,607,656		$	7,620,878		$	(13,222	)	-0.2	%
Consolidated capital ratios
Equity to assets			10.03	%		9.94	%		0.09	%
Tangible equity to tangible assets (1)			8.65	%		8.56	%		0.09	%
Share data
Outstanding shares			64,739			64,739			—		—	%
Book value per share		$	11.79		$	11.70		$	0.09		0.8	%
Tangible book value per share (2)		$	10.02		$	9.93		$	0.09		0.9	%

_________________________
(1)	Tangible equity equals total stockholders’ equity reduced by goodwill and core deposit intangible assets. Tangible assets equals total assets reduced by goodwill and core deposit intangible assets.
(2)	Tangible book value equals total stockholders’ equity reduced by goodwill and core deposit intangible assets.

Kearny Financial Corp. Consolidated Statements of Income (Unaudited)
(Dollars and Shares in Thousands, Except Per Share Data)		Three Months Ended						Variance or Change			Variance or Change Pct.
		March 31, 2026			December 31, 2025
Interest income
Loans		$	66,310		$	67,410		$	(1,100	)	-1.6	%
Taxable investment securities			11,425			11,623			(198	)	-1.7	%
Tax-exempt investment securities			34			35			(1	)	-2.9	%
Other interest-earning assets			1,400			1,584			(184	)	-11.6	%
Total interest income			79,169			80,652			(1,483	)	-1.8	%
Interest expense
Deposits			31,045			33,148			(2,103	)	-6.3	%
Borrowings			8,888			9,535			(647	)	-6.8	%
Total interest expense			39,933			42,683			(2,750	)	-6.4	%
Net interest income			39,236			37,969			1,267		3.3	%
Provision for credit losses			391			567			(176	)	-31.0	%
Net interest income after provision for credit losses			38,845			37,402			1,443		3.9	%
Non-interest income
Fees and service charges			922			1,295			(373	)	-28.8	%
Gain on sale of loans			193			224			(31	)	-13.8	%
Income from bank owned life insurance			2,646			2,710			(64	)	-2.4	%
Electronic banking fees and charges			389			473			(84	)	-17.8	%
Other income			1,944			869			1,075		123.7	%
Total non-interest income			6,094			5,571			523		9.4	%
Non-interest expense
Salaries and employee benefits			19,316			18,373			943		5.1	%
Net occupancy expense of premises			3,263			2,888			375		13.0	%
Equipment and systems			3,975			4,007			(32	)	-0.8	%
Advertising and marketing			665			412			253		61.4	%
Federal deposit insurance premium			1,302			1,357			(55	)	-4.1	%
Directors’ compensation			307			306			1		0.3	%
Other expense			3,471			3,848			(377	)	-9.8	%
Total non-interest expense			32,299			31,191			1,108		3.6	%
Income before income taxes			12,640			11,782			858		7.3	%
Income taxes			2,503			2,333			170		7.3	%
Net income		$	10,137		$	9,449		$	688		7.3	%
Net income per common share (EPS)
Basic		$	0.16		$	0.15		$	0.01
Diluted		$	0.16		$	0.15		$	0.01
Dividends declared
Cash dividends declared per common share		$	0.11		$	0.11		$	—
Cash dividends declared		$	7,005		$	6,987		$	18
Dividend payout ratio			69.1	%		73.9	%		-4.8	%
Weighted average number of common shares outstanding
Basic			62,908			62,858			50
Diluted			63,251			63,061			190

Kearny Financial Corp. Average Balance Sheet Data (Unaudited)
(Dollars in Thousands)		Three Months Ended						Variance or Change			Variance or Change Pct.
		March 31, 2026			December 31, 2025
Assets
Interest-earning assets:
Loans receivable, including loans held for sale		$	5,785,095		$	5,778,680		$	6,415		0.1	%
Taxable investment securities			1,194,487			1,185,602			8,885		0.7	%
Tax-exempt investment securities			5,669			5,902			(233	)	-3.9	%
Other interest-earning assets			106,967			123,475			(16,508	)	-13.4	%
Total interest-earning assets			7,092,218			7,093,659			(1,441	)	-0.0	%
Non-interest-earning assets			455,725			455,752			(27	)	-0.0	%
Total assets		$	7,547,943		$	7,549,411		$	(1,468	)	-0.0	%
Liabilities and Stockholders’ Equity
Interest-bearing liabilities:
Deposits:
Interest-bearing demand		$	2,402,177		$	2,385,397		$	16,780		0.7	%
Savings			761,090			759,247			1,843		0.2	%
Certificates of deposit (retail)			1,181,526			1,201,950			(20,424	)	-1.7	%
Certificates of deposit (brokered)			755,461			756,179			(718	)	-0.1	%
Total interest-bearing deposits			5,100,254			5,102,773			(2,519	)	-0.0	%
Borrowings:
Federal Home Loan Bank advances			861,445			998,760			(137,315	)	-13.7	%
Other borrowings			133,833			38,478			95,355		247.8	%
Total borrowings			995,278			1,037,238			(41,960	)	-4.0	%
Total interest-bearing liabilities			6,095,532			6,140,011			(44,479	)	-0.7	%
Non-interest-bearing liabilities:
Non-interest-bearing deposits			633,494			595,035			38,459		6.5	%
Other non-interest-bearing liabilities			59,644			59,447			197		0.3	%
Total non-interest-bearing liabilities			693,138			654,482			38,656		5.9	%
Total liabilities			6,788,670			6,794,493			(5,823	)	-0.1	%
Stockholders’ equity			759,273			754,918			4,355		0.6	%
Total liabilities and stockholders’ equity		$	7,547,943		$	7,549,411		$	(1,468	)	-0.0	%
Average interest-earning assets to average interest-bearing liabilities			116.35	%		115.53	%		0.82	%	0.7	%

Kearny Financial Corp. Performance Ratio Highlights (Unaudited)
		Three Months Ended				Variance or Change
		March 31, 2026		December 31, 2025
Average yield on interest-earning assets:
Loans receivable, including loans held for sale		4.58	%	4.67	%	-0.09	%
Taxable investment securities		3.83	%	3.92	%	-0.09	%
Tax-exempt investment securities (1)		2.37	%	2.36	%	0.01	%
Other interest-earning assets		5.24	%	5.13	%	0.11	%
Total interest-earning assets		4.47	%	4.55	%	-0.08	%
Average cost of interest-bearing liabilities:
Deposits:
Interest-bearing demand		2.34	%	2.51	%	-0.17	%
Savings		1.26	%	1.40	%	-0.14	%
Certificates of deposit (retail)		3.20	%	3.45	%	-0.25	%
Certificates of deposit (brokered)		2.71	%	2.72	%	-0.01	%
Total interest-bearing deposits		2.43	%	2.60	%	-0.17	%
Borrowings:
Federal Home Loan Bank advances		3.56	%	3.66	%	-0.10	%
Other borrowings		3.66	%	4.13	%	-0.47	%
Total borrowings		3.57	%	3.68	%	-0.11	%
Total interest-bearing liabilities		2.62	%	2.78	%	-0.16	%
Interest rate spread (2)		1.85	%	1.77	%	0.08	%
Net interest margin (3)		2.21	%	2.14	%	0.07	%
Non-interest income to average assets (annualized)		0.32	%	0.30	%	0.02	%
Non-interest expense to average assets (annualized)		1.71	%	1.65	%	0.06	%
Efficiency ratio (4)		71.25	%	71.64	%	-0.39	%
Return on average assets (annualized)		0.54	%	0.50	%	0.04	%
Return on average equity (annualized)		5.34	%	5.01	%	0.33	%
Return on average tangible equity (annualized) (5)		6.34	%	5.96	%	0.38	%

_________________________
(1)	The yield on tax-exempt investment securities has not been adjusted to reflect their tax-effective yield.
(2)	Interest income divided by average interest-earning assets less interest expense divided by average interest-bearing liabilities.
(3)	Net interest income divided by average interest-earning assets.
(4)	Non-interest expense divided by the sum of net interest income and non-interest income.
(5)	Average tangible equity equals total average stockholders’ equity reduced by average goodwill and average core deposit intangible assets.

Five-Quarter Financial Trend Analysis

Kearny Financial Corp. Consolidated Balance Sheets
(Dollars and Shares in Thousands, Except Per Share Data)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
		(Unaudited)			(Unaudited)			(Unaudited)			(Audited)			(Unaudited)
Assets
Cash and cash equivalents		$	123,836		$	147,340		$	130,139		$	167,269		$	126,095
Securities available for sale			983,325			1,000,397			1,016,182			1,012,969			1,003,393
Securities held to maturity			110,581			112,800			116,681			120,217			124,859
Loans held-for-sale			12,183			8,786			6,650			5,931			6,187
Loans receivable			5,779,181			5,753,393			5,767,419			5,812,937			5,846,175
Less: allowance for credit losses on loans			(44,723	)		(44,958	)		(45,060	)		(46,191	)		(44,455	)
Net loans receivable			5,734,458			5,708,435			5,722,359			5,766,746			5,801,720
Premises and equipment			41,896			42,559			43,222			43,897			44,192
Federal Home Loan Bank stock			55,737			57,212			62,011			64,261			62,261
Accrued interest receivable			28,304			27,420			29,460			28,098			28,521
Goodwill			113,525			113,525			113,525			113,525			113,525
Core deposit intangible			1,080			1,198			1,317			1,436			1,554
Bank owned life insurance			312,050			309,404			307,248			304,717			303,629
Deferred income taxes, net			50,961			51,617			51,587			55,203			52,913
Other assets			39,720			40,185			47,629			56,181			64,292
Total assets		$	7,607,656		$	7,620,878		$	7,648,010		$	7,740,450		$	7,733,141
Liabilities
Deposits:
Non-interest-bearing		$	631,506		$	627,180		$	578,481		$	582,045		$	587,118
Interest-bearing			5,097,576			5,084,370			5,053,401			5,093,172			5,120,230
Total deposits			5,729,082			5,711,550			5,631,882			5,675,217			5,707,348
Borrowings			1,060,000			1,095,000			1,206,497			1,256,491			1,213,976
Advance payments by borrowers for taxes			19,317			18,474			19,261			19,317			19,981
Other liabilities			36,225			38,458			37,166			43,463			43,723
Total liabilities			6,844,624			6,863,482			6,894,806			6,994,488			6,985,028
Stockholders’ Equity
Common stock			648			648			648			646			646
Paid-in capital			495,442			494,959			494,490			494,546			494,131
Retained earnings			349,881			346,749			344,287			341,744			341,921
Unearned ESOP shares			(17,511	)		(17,997	)		(18,484	)		(18,970	)		(19,457	)
Accumulated other comprehensive loss			(65,428	)		(66,963	)		(67,737	)		(72,004	)		(69,128	)
Total stockholders’ equity			763,032			757,396			753,204			745,962			748,113
Total liabilities and stockholders’ equity		$	7,607,656		$	7,620,878		$	7,648,010		$	7,740,450		$	7,733,141
Consolidated capital ratios
Equity to assets			10.03	%		9.94	%		9.85	%		9.64	%		9.67	%
Tangible equity to tangible assets (1)			8.65	%		8.56	%		8.47	%		8.27	%		8.31	%
Share data
Outstanding shares			64,739			64,739			64,739			64,577			64,580
Book value per share		$	11.79		$	11.70		$	11.63		$	11.55		$	11.58
Tangible book value per share (2)		$	10.02		$	9.93		$	9.86		$	9.77		$	9.80

_________________________
(1)	Tangible equity equals total stockholders’ equity reduced by goodwill and core deposit intangible assets. Tangible assets equals total assets reduced by goodwill and core deposit intangible assets.
(2)	Tangible book value equals total stockholders’ equity reduced by goodwill and core deposit intangible assets.

Kearny Financial Corp. Supplemental Balance Sheet Highlights (Unaudited)
(Dollars in Thousands)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Loan portfolio composition:
Commercial loans:
Multi-family mortgage		$	2,555,001		$	2,619,124		$	2,640,737		$	2,709,654		$	2,733,406
Nonresidential mortgage			1,012,422			990,178			988,969			986,556			988,074
Commercial business			201,277			169,884			142,304			138,755			140,224
Construction			207,765			181,766			189,626			177,713			174,722
Total commercial loans			3,976,465			3,960,952			3,961,636			4,012,678			4,036,426
One- to four-family residential mortgage			1,741,023			1,730,543			1,749,362			1,748,591			1,761,465
Consumer loans:
Home equity loans			61,379			59,046			54,116			50,737			49,699
Other consumer			2,377			2,523			2,487			2,533			2,859
Total consumer loans			63,756			61,569			56,603			53,270			52,558
Total loans, excluding yield adjustments			5,781,244			5,753,064			5,767,601			5,814,539			5,850,449
Unaccreted yield adjustments			(2,063	)		329			(182	)		(1,602	)		(4,274	)
Loans receivable, net of yield adjustments			5,779,181			5,753,393			5,767,419			5,812,937			5,846,175
Less: allowance for credit losses on loans			(44,723	)		(44,958	)		(45,060	)		(46,191	)		(44,455	)
Net loans receivable		$	5,734,458		$	5,708,435		$	5,722,359		$	5,766,746		$	5,801,720
Asset quality:
Nonperforming assets:
Accruing loans – 90 days and over past due		$	—		$	—		$	20,494		$	—		$	—
Nonaccrual loans			52,379			51,306			44,085			45,597			37,683
Total nonperforming loans			52,379			51,306			64,579			45,597			37,683
Nonaccrual loans held-for-sale			—			—			—			—			—
Other real estate owned			—			—			—			—			—
Total nonperforming assets		$	52,379		$	51,306		$	64,579		$	45,597		$	37,683
Nonperforming loans (% total loans)			0.91	%		0.89	%		1.12	%		0.78	%		0.64	%
Nonperforming assets (% total assets)			0.69	%		0.67	%		0.84	%		0.59	%		0.49	%
Classified loans		$	97,384		$	97,542		$	117,780		$	118,418		$	113,470
Allowance for credit losses on loans (ACL):
ACL to total loans			0.77	%		0.78	%		0.78	%		0.79	%		0.76	%
ACL to nonperforming loans			85.38	%		87.63	%		69.78	%		101.30	%		117.97	%
Net charge-offs		$	626		$	669		$	1,049		$	49		$	368
Average net charge-off rate (annualized)			0.04	%		0.05	%		0.07	%		0.00	%		0.03	%

Kearny Financial Corp. Supplemental Balance Sheet Highlights (Unaudited)
(Dollars in Thousands)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Funding composition:
Deposits:
Non-interest-bearing deposits		$	631,506		$	627,180		$	578,481		$	582,045		$	587,118
Interest-bearing demand			2,375,565			2,376,825			2,334,560			2,362,222			2,410,925
Savings			763,016			769,742			751,253			754,376			758,239
Certificates of deposit (retail)			1,201,752			1,180,370			1,208,408			1,218,920			1,218,479
Certificates of deposit (brokered)			757,243			757,433			759,180			757,654			732,587
Interest-bearing deposits			5,097,576			5,084,370			5,053,401			5,093,172			5,120,230
Total deposits			5,729,082			5,711,550			5,631,882			5,675,217			5,707,348
Borrowings:
Federal Home Loan Bank advances			900,000			800,000			1,006,497			1,106,491			1,028,976
Overnight borrowings			160,000			295,000			200,000			150,000			185,000
Total borrowings			1,060,000			1,095,000			1,206,497			1,256,491			1,213,976
Total funding		$	6,789,082		$	6,806,550		$	6,838,379		$	6,931,708		$	6,921,324
Loans as a % of deposits			100.3	%		100.1	%		101.7	%		101.7	%		101.8	%
Deposits as a % of total funding			84.4	%		83.9	%		82.4	%		81.9	%		82.5	%
Borrowings as a % of total funding			15.6	%		16.1	%		17.6	%		18.1	%		17.5	%
Uninsured deposits:
Uninsured deposits (reported) (1)		$	2,199,708		$	2,158,440		$	2,040,021		$	1,989,095		$	1,959,070
Uninsured deposits (adjusted) (2)		$	839,094		$	800,998		$	804,209		$	813,780		$	799,238

_________________________
(1)	Uninsured deposits of Kearny Bank.
(2)	Uninsured deposits of Kearny Bank adjusted to exclude deposits of its wholly-owned subsidiary and holding company and collateralized deposits of state and local governments.

Kearny Financial Corp. Consolidated Statements of Income (Unaudited)
		Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Interest income
Loans		$	66,310		$	67,410		$	68,349		$	66,485		$	64,768
Taxable investment securities			11,425			11,623			12,600			12,322			12,738
Tax-exempt investment securities			34			35			41			49			55
Other interest-earning assets			1,400			1,584			1,518			1,549			1,773
Total interest income			79,169			80,652			82,508			80,405			79,334
Interest expense
Deposits			31,045			33,148			33,931			33,607			34,912
Borrowings			8,888			9,535			10,873			10,955			10,380
Total interest expense			39,933			42,683			44,804			44,562			45,292
Net interest income			39,236			37,969			37,704			35,843			34,042
Provision for (reversal of) credit losses			391			567			(82	)		1,785			366
Net interest income after provision for (reversal of) credit losses			38,845			37,402			37,786			34,058			33,676
Non-interest income
Fees and service charges			922			1,295			892			655			573
Gain on sale of loans			193			224			199			190			112
Income from bank owned life insurance			2,646			2,710			2,689			2,869			2,617
Electronic banking fees and charges			389			473			416			442			391
Other income			1,944			869			1,651			835			869
Total non-interest income			6,094			5,571			5,847			4,991			4,562
Non-interest expense
Salaries and employee benefits			19,316			18,373			18,745			18,093			17,700
Net occupancy expense of premises			3,263			2,888			3,307			2,820			3,075
Equipment and systems			3,975			4,007			3,974			4,030			3,921
Advertising and marketing			665			412			562			615			609
Federal deposit insurance premium			1,302			1,357			1,301			1,395			1,450
Directors’ compensation			307			306			307			307			326
Other expense			3,471			3,848			3,470			3,633			3,309
Total non-interest expense			32,299			31,191			31,666			30,893			30,390
Income before income taxes			12,640			11,782			11,967			8,156			7,848
Income taxes			2,503			2,333			2,461			1,387			1,200
Net income		$	10,137		$	9,449		$	9,506		$	6,769		$	6,648
Net income per common share (EPS)
Basic		$	0.16		$	0.15		$	0.15		$	0.11		$	0.11
Diluted		$	0.16		$	0.15		$	0.15		$	0.11		$	0.11
Dividends declared
Cash dividends declared per common share		$	0.11		$	0.11		$	0.11		$	0.11		$	0.11
Cash dividends declared		$	7,005		$	6,987		$	6,963		$	6,946		$	6,933
Dividend payout ratio			69.1	%		73.9	%		73.2	%		102.6	%		104.3	%
Weighted average number of common shares outstanding
Basic			62,908			62,858			62,741			62,597			62,548
Diluted			63,251			63,061			62,951			62,755			62,713

Kearny Financial Corp. Average Balance Sheet Data (Unaudited)
		Three Months Ended
(Dollars in Thousands)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Assets
Interest-earning assets:
Loans receivable, including loans held-for-sale		$	5,785,095		$	5,778,680		$	5,806,767		$	5,830,421		$	5,805,045
Taxable investment securities			1,194,487			1,185,602			1,236,705			1,227,825			1,251,612
Tax-exempt investment securities			5,669			5,902			6,856			8,039			9,135
Other interest-earning assets			106,967			123,475			115,776			117,622			110,736
Total interest-earning assets			7,092,218			7,093,659			7,166,104			7,183,907			7,176,528
Non-interest-earning assets			455,725			455,752			453,215			454,975			457,206
Total assets		$	7,547,943		$	7,549,411		$	7,619,319		$	7,638,882		$	7,633,734
Liabilities and Stockholders’ Equity
Interest-bearing liabilities:
Deposits:
Interest-bearing demand		$	2,402,177		$	2,385,397		$	2,343,809		$	2,342,523		$	2,405,974
Savings			761,090			759,247			754,244			754,192			751,243
Certificates of deposit (retail)			1,181,526			1,201,950			1,211,026			1,215,661			1,215,767
Certificates of deposit (brokered)			755,461			756,179			755,813			744,345			730,612
Total interest-bearing deposits			5,100,254			5,102,773			5,064,892			5,056,721			5,103,596
Borrowings:
Federal Home Loan Bank advances			861,445			998,760			1,077,146			1,083,902			1,028,958
Other borrowings			133,833			38,478			85,489			107,582			93,389
Total borrowings			995,278			1,037,238			1,162,635			1,191,484			1,122,347
Total interest-bearing liabilities			6,095,532			6,140,011			6,227,527			6,248,205			6,225,943
Non-interest-bearing liabilities:
Non-interest-bearing deposits			633,494			595,035			581,625			582,085			602,647
Other non-interest-bearing liabilities			59,644			59,447			65,024			64,405			59,919
Total non-interest-bearing liabilities			693,138			654,482			646,649			646,490			662,566
Total liabilities			6,788,670			6,794,493			6,874,176			6,894,695			6,888,509
Stockholders’ equity			759,273			754,918			745,143			744,187			745,225
Total liabilities and stockholders’ equity		$	7,547,943		$	7,549,411		$	7,619,319		$	7,638,882		$	7,633,734
Average interest-earning assets to average interest-bearing liabilities			116.35	%		115.53	%		115.07	%		114.98	%		115.27	%

Kearny Financial Corp. Performance Ratio Highlights
		Three Months Ended
		March 31, 2026		December 31, 2025		September 30, 2025		June 30, 2025		March 31, 2025
Average yield on interest-earning assets:
Loans receivable, including loans held-for-sale		4.58	%	4.67	%	4.71	%	4.56	%	4.46	%
Taxable investment securities		3.83	%	3.92	%	4.08	%	4.01	%	4.07	%
Tax-exempt investment securities (1)		2.37	%	2.36	%	2.42	%	2.43	%	2.43	%
Other interest-earning assets		5.24	%	5.13	%	5.24	%	5.27	%	6.40	%
Total interest-earning assets		4.47	%	4.55	%	4.61	%	4.48	%	4.42	%
Average cost of interest-bearing liabilities:
Deposits:
Interest-bearing demand		2.34	%	2.51	%	2.63	%	2.63	%	2.73	%
Savings		1.26	%	1.40	%	1.41	%	1.33	%	1.30	%
Certificates of deposit (retail)		3.20	%	3.45	%	3.56	%	3.56	%	3.73	%
Certificates of deposit (brokered)		2.71	%	2.72	%	2.67	%	2.62	%	2.58	%
Total interest-bearing deposits		2.43	%	2.60	%	2.68	%	2.66	%	2.74	%
Borrowings:
Federal Home Loan Bank advances		3.56	%	3.66	%	3.69	%	3.60	%	3.63	%
Other borrowings		3.66	%	4.13	%	4.44	%	4.45	%	4.41	%
Total borrowings		3.57	%	3.68	%	3.74	%	3.68	%	3.70	%
Total interest-bearing liabilities		2.62	%	2.78	%	2.88	%	2.85	%	2.91	%
Interest rate spread (2)		1.85	%	1.77	%	1.73	%	1.62	%	1.51	%
Net interest margin (3)		2.21	%	2.14	%	2.10	%	2.00	%	1.90	%
Non-interest income to average assets (annualized)		0.32	%	0.30	%	0.31	%	0.26	%	0.24	%
Non-interest expense to average assets (annualized)		1.71	%	1.65	%	1.66	%	1.62	%	1.59	%
Efficiency ratio (4)		71.25	%	71.64	%	72.71	%	75.66	%	78.72	%
Return on average assets (annualized)		0.54	%	0.50	%	0.50	%	0.35	%	0.35	%
Return on average equity (annualized)		5.34	%	5.01	%	5.10	%	3.64	%	3.57	%
Return on average tangible equity (annualized) (5)		6.34	%	5.96	%	6.09	%	4.36	%	4.28	%

_________________________
(1)	The yield on tax-exempt investment securities has not been adjusted to reflect their tax-effective yield.
(2)	Interest income divided by average interest-earning assets less interest expense divided by average interest-bearing liabilities.
(3)	Net interest income divided by average interest-earning assets.
(4)	Non-interest expense divided by the sum of net interest income and non-interest income.
(5)	Average tangible equity equals total average stockholders’ equity reduced by average goodwill and average core deposit intangible assets.

The following tables provide a reconciliation of certain financial measures calculated in accordance with Generally Accepted Accounting Principles (“GAAP”) (as reported) and non-GAAP measures. These non-GAAP measures provide additional information which allow readers to evaluate the ongoing performance of the Company. They are not a substitute for GAAP measures; they should be read and used in conjunction with the Company’s GAAP financial information. In all cases, it should be understood that non-GAAP per share measures do not depict amounts that accrue directly to the benefit of shareholders.

Kearny Financial Corp. Reconciliation of GAAP to Non-GAAP (Unaudited)
		Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Adjusted net income:
Net income (GAAP)		$	10,137		$	9,449		$	9,506		$	6,769		$	6,648
Non-recurring transactions – net of tax:
Branch consolidation expenses			—			—			178			—			—
Gain on sale of property held for sale			(724	)		—			(532	)		—			—
Adjusted net income		$	9,413		$	9,449		$	9,152		$	6,769		$	6,648
Calculation of pre-tax, pre-provision net revenue:
Net income (GAAP)		$	10,137		$	9,449		$	9,506		$	6,769		$	6,648
Adjustments to net income (GAAP):
Provision for income taxes			2,503			2,333			2,461			1,387			1,200
Provision for (reversal of) credit losses			391			567			(82	)		1,785			366
Pre-tax, pre-provision net revenue (non-GAAP)		$	13,031		$	12,349		$	11,885		$	9,941		$	8,214
Adjusted earnings per share:
Weighted average common shares – basic			62,908			62,858			62,741			62,597			62,548
Weighted average common shares – diluted			63,251			63,061			62,951			62,755			62,713
Earnings per share – basic (GAAP)		$	0.16		$	0.15		$	0.15		$	0.11		$	0.11
Earnings per share – diluted (GAAP)		$	0.16		$	0.15		$	0.15		$	0.11		$	0.11
Adjusted earnings per share – basic (non-GAAP)		$	0.15		$	0.15		$	0.15		$	0.11		$	0.11
Adjusted earnings per share – diluted (non-GAAP)		$	0.15		$	0.15		$	0.15		$	0.11		$	0.11
Pre-tax, pre-provision net revenue per share:
Pre-tax, pre-provision net revenue per share – basic (non-GAAP)		$	0.21		$	0.20		$	0.19		$	0.16		$	0.13
Pre-tax, pre-provision net revenue per share – diluted (non-GAAP)		$	0.21		$	0.20		$	0.19		$	0.16		$	0.13
Adjusted return on average assets:
Total average assets		$	7,547,943		$	7,549,411		$	7,619,319		$	7,638,882		$	7,633,734
Return on average assets (GAAP)			0.54	%		0.50	%		0.50	%		0.35	%		0.35	%
Adjusted return on average assets (non-GAAP)			0.50	%		0.50	%		0.48	%		0.35	%		0.35	%
Adjusted return on average equity:
Total average equity		$	759,273		$	754,918		$	745,143		$	744,187		$	745,225
Return on average equity (GAAP)			5.34	%		5.01	%		5.10	%		3.64	%		3.57	%
Adjusted return on average equity (non-GAAP)			4.96	%		5.01	%		4.91	%		3.64	%		3.57	%

Kearny Financial Corp. Reconciliation of GAAP to Non-GAAP (Unaudited)
		Three Months Ended
(Dollars and Shares in Thousands, Except Per Share Data)		March 31, 2026			December 31, 2025			September 30, 2025			June 30, 2025			March 31, 2025
Adjusted return on average tangible equity:
Total average equity		$	759,273		$	754,918		$	745,143		$	744,187		$	745,225
Less: average goodwill			(113,525	)		(113,525	)		(113,525	)		(113,525	)		(113,525	)
Less: average other intangible assets			(1,157	)		(1,276	)		(1,395	)		(1,513	)		(1,636	)
Total average tangible equity		$	644,591		$	640,117		$	630,223		$	629,149		$	630,064
Return on average tangible equity (non-GAAP)			6.34	%		5.96	%		6.09	%		4.36	%		4.28	%
Adjusted return on average tangible equity (non-GAAP)			5.90	%		5.96	%		5.87	%		4.36	%		4.28	%
Adjusted non-interest expense ratio:
Non-interest expense (GAAP)		$	32,299		$	31,191		$	31,666		$	30,893		$	30,390
Non-recurring transactions:
Branch consolidation expenses			—			—			(250	)		—			—
Non-interest expense (non-GAAP)		$	32,299		$	31,191		$	31,416		$	30,893		$	30,390
Non-interest expense ratio (GAAP)			1.71	%		1.65	%		1.66	%		1.62	%		1.59	%
Adjusted non-interest expense ratio (non-GAAP)			1.71	%		1.65	%		1.65	%		1.62	%		1.59	%
Adjusted efficiency ratio:
Non-interest expense (non-GAAP)		$	32,299		$	31,191		$	31,416		$	30,893		$	30,390
Net interest income (GAAP)		$	39,236		$	37,969		$	37,704		$	35,843		$	34,042
Total non-interest income (GAAP)			6,094			5,571			5,847			4,991			4,562
Non-recurring transactions:
Gain on sale of property held for sale			(1,020	)		—			(749	)		—			—
Total revenue (non-GAAP)		$	44,310		$	43,540		$	42,802		$	40,834		$	38,604
Efficiency ratio (GAAP)			71.25	%		71.64	%		72.71	%		75.66	%		78.72	%
Adjusted efficiency ratio (non-GAAP)			72.89	%		71.64	%		73.40	%		75.66	%		78.72	%

For further information contact:
Keith Suchodolski, Senior Executive Vice President and Chief Operating Officer, or
Sean Byrnes, Executive Vice President and Chief Financial Officer
Kearny Financial Corp.
(973) 244-4500

MINNEAPOLIS, April 23, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it will participate in the AATS 106^th Annual Meeting taking place May 2–5 in Chicago. The Company will be showcasing its Aquadex SmartFlow® ultrafiltration system for fluid removal at Booth 530. At the start of the event, Nuwellis will attend the ERAS Cardiac Spring Retreat gathering of thought leaders, to discuss best practices and innovation in cardiac surgery care.

“AATS is one of the largest congresses in the cardiothoracic arena, and a unique opportunity to showcase our Aquadex technology, and discuss new updates, including ongoing advancements in precision ultrafiltration therapy,” said Nuwellls’ CEO John Erb. “At the ERAS Cardiac retreat, experts and thought leaders will discuss key issues facing practitioners today. Inclusion in this event is an important opportunity for Nuwellis to connect with industry colleagues in a lively dialogue, and we look forward to our annual participation.”

The AATS 106^th Annual Meeting is a premier cardiothoracic surgery event, bringing together leading experts from around the world to share best practices, explore cutting-edge innovations, and advance the field. ERAS Cardiac is a nonprofit organization focused on enhancing perioperative care in adult cardiac surgery.

For more information on the AATS 106^th Annual Meeting, visit the event’s website.

About Nuwellis

Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company committed to delivering solutions for patients with cardiorenal conditions. The Company develops solutions designed to support patient care through monitoring, therapy, and data-informed clinical decision-making across acute and chronic care settings. Nuwellis’ portfolio includes commercially available and development-stage technologies addressing complex cardiorenal conditions, with a focus on safety, precision, and scalability across patient populations. For more information, visit www.nuwellis.com.

Forward-Looking Statements

Certain statements in this release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the new market opportunities and anticipated growth in 2026 and beyond. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risks associated with our ability to execute on our commercialization strategy, the possibility that we may be unable to raise sufficient funds necessary for our anticipated operations, our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Nuwellis does not assume any obligation to publicly update or revise any forward-looking statements, whether due to new information, future events or otherwise.

For further information, please contact:

Investor Relations:

[email protected]

Media Contact:

CORE PR
[email protected]

Nes-Ziona, Israel, April 23, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that it will present two poster abstracts at the Osteoarthritis Research Society International (OARSI) 2026 World Congress on Osteoarthritis, taking place April 23-26, 2026, in West Palm Beach, Florida, USA.

The presentations will feature 3-month and 6-month endpoints clinical data from the Phase IIa (NCT06233474) for Allocetra™ in patients with moderate-to-severe knee osteoarthritis (KOA).  The Phase IIa data demonstrated clinically meaningful and statistically significant improvement of the Allocetra™-treated arm in reduction of pain and improvement of function, compared to the control placebo arm, in idiopathic age-related osteoarthritis patients (≥60 years), representing more than 50% of the total KOA market. 

The data will be presented by Prof. Philip Conaghan, Consultant Rheumatologist and Director of the NIHR Leeds Biomedical Research Centre. Professor Conaghan is an international leader in osteoarthritis and musculoskeletal imaging, who has authored more than 700 publications and chaired multiple global guidelines and trial initiatives. In addition, the Company will present comprehensive pharmacological characterization data supporting the novel immunomodulating mechanism of action of Allocetra^TM.

Oren Hershkovitz, Ph.D, CEO of Enlivex, commented “We are pleased that the OARSI 2026 team selected Enlivex to present this data at the 2026 World Congress on Osteoarthritis, which is the leading international congress on the topic of osteoarthritis. We look forward to presenting the depth of our clinical and pharmacological program for Allocetra™, including three-month and six-month efficacy and mechanistic characterization data behind our unique approach to addressing inflammatory, age-related joint disease.”

Poster Presentations:

Title: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA TRIAL OF ALLOCETRA^TM – AN INNOVATIVE INTRA-ARTICULAR APOPTOTIC CELL THERAPY IN KNEE OSTEOARTHRITIS DEMONSTRATES DURABLE EFFICACY AT 6 MONTHS (NCT06233474)

• Abstract ID: 4466183
• Poster Number: 405
• Date & Time: April 24 & 25 2026 | 03:30 PM – 04:15 PM ET

Title: PHARMACOLOGICAL CHARACTERIZATION OF ALLOCETRA^TM; A NOVELMACROPHAGE REPROGRAMMING CELL THERAPY, FOR INTRA ARTICULARTREATMENT IN OSTEOARTHRITIS

• Abstract ID: 4466242
• Poster Number: 549
• Date & Time: April 24 & 25 2026 | 03:30 PM – 04:15 PM ET

About Enlivex (Nasdaq: ENLV)

Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis.

In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the RAIN token, which is the token of the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would,” “could,” “intends,” “estimates,” “suggests,” “target,” “has the potential to,” “goal,” and other words of similar meaning, including statements relating to the anticipated benefits of the Company’s digital asset treasury strategy; the assets to be held by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on the liquidity of the Company’s ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets; the Company’s plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions; competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities for, ALLOCETRA™ programs. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure to realize the anticipated benefits of the Company’s digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company’s operations and business, including the highly volatile nature of the price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading venues, and market infrastructure; the risk that the price and liquidity of the Company’s ordinary shares may be correlated with the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required by applicable law.

ENLIVEX CONTACT

Shachar Shlosberger, CFO
Enlivex Ltd.
[email protected]

Passin, recently appointed to the Board, brings over two decades of institutional uranium investment expertise to help lead the Company’s strategic direction

Frederico Figueira de Chaves appointed CEO, bringing deep knowledge of the Company’s strategy and operations

Dublin, April 23, 2026 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced changes to its Board of Directors (the “Board”) and senior management. James Passin, who was recently appointed to the Board, has been appointed Chairman of the Board, and Frederico Figueira de Chaves has been appointed Chief Executive Officer (“CEO”). John-Paul (JP) Backwell has stepped down as Chairman and CEO due to personal and health reasons following his tenure with the Company. Mr. Backwell will continue to serve on the Board as a non-executive director, while supporting the Company in a consulting capacity.

James Passin brings to the Chairmanship a depth of strategic vision and institutional market knowledge that the Board believes is uniquely suited to Fusion Fuel’s current direction. A pioneer of uranium investing, Mr. Passin made uranium exploration and mining a core focus at Firebird Management LLC as early as 2000 — when uranium traded below $8 per pound and institutional interest in the sector was virtually non-existent. Uranium subsequently rallied to over $135 per pound by 2007. He exited all uranium positions ahead of the post-2007 price correction.

During his tenure at Firebird Management LLC, Mr. Passin directed and managed a resource portfolio in excess of $1 billion, developing deep expertise across early-stage resource companies in the Americas, Central Asia, Africa, and frontier markets globally. He was described by the Financial Times as “The Indiana Jones of frontier markets” and by The New York Times as a “daredevil investor” — recognitions that reflect a consistent track record of identifying transformational investment opportunities ahead of consensus. The Board believes Mr. Passin’s appointment as Chairman will provide strong strategic leadership as the Company pursues its uranium royalty platform and evaluates further growth opportunities across energy commodities.

“I am honored to take on the role of Chairman at what I believe is a pivotal moment for Fusion Fuel,” said Mr. Passin. “We believe uranium and critical elements are entering a structural upcycle driven by energy security imperatives, growing nuclear capacity commitments, and surging electricity demand from artificial intelligence infrastructure — and Fusion Fuel is positioning itself to participate in that cycle through a capital-efficient royalty model. I want to recognize JP’s exceptional leadership and the lasting impact of his contributions to the Company during a critical period of significant operational and strategic transformation. I look forward to working alongside Frederico and the full Board to take Fusion Fuel to the next level.”

Mr. Figueira de Chaves has been appointed Chief Executive Officer, in addition to his continuing roles as Interim Chief Financial Officer and Chief Strategy Officer. His appointment reflects the Board’s confidence in his deep, hands-on knowledge of Fusion Fuel’s strategy, its ongoing transactions, and its operational platforms.

Mr. Figueira de Chaves has served in several senior roles at the Company since 2020. Mr. Figueira de Chaves served as Chief Financial Officer of the Company from June 2020 to June 2023, as CEO from June 2023 to November 2024, as a director since June 2020, as Chief Strategy Officer since November 2024, and as Interim Chief Financial Officer since January 2025. He previously held senior positions at UBS AG, including Chief of Staff roles to the Global Asset Management CEO, the CEO of Europe, the Middle East, and Africa (“EMEA”), and the Group COO. He holds a master’s degree in economics from the University of Edinburgh.

“I am grateful for the confidence the Board has placed in me,” said Mr. Figueira de Chaves. “Fusion Fuel is at an exciting inflection point. I look forward to working closely with James as Chairman, with JP in his continued advisory role, and with the entire Board and management team to execute on our strategy and deliver meaningful results for our shareholders.”

The Board extends its deep appreciation to Mr. Backwell for his leadership and significant contributions during a pivotal period in Fusion Fuel’s evolution. Under his leadership, Fusion Fuel launched Bright Hydrogen Solutions Limited (“BrightHy Solutions”) and Biosteam Energy (Proprietary) Limited (“BioSteam Energy”), advanced the growth of Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), secured critical capital, and entered into an agreement to acquire Royal Uranium Inc. (“Royal Uranium”), the holder of certain uranium, natural gas and other mineral assets royalties.

Mr. Backwell will remain on the Board as a director and has entered a consulting arrangement to support the execution of ongoing transactions and the continued growth of the Company’s operations.

Mr. Backwell stated, “I have strong confidence in both James and Frederico to take the Company forward, and I remain fully committed to supporting the Board and management team as we execute on our strategic initiatives.”

The Company intends to hold an investor update call following the anticipated announcement of the Extraordinary General Meeting (the “EGM”) in connection with the Company’s contemplated transaction with Royal Uranium, the closing of which remains subject to shareholder approval at the EGM and satisfaction of other customary closing conditions. Further details will be announced in due course.

About Fusion Fuel Green PLC

Fusion Fuel Green PLC (NASDAQ: HTOO) provides integrated energy engineering, distribution, and green hydrogen solutions through its Al Shola Gas, BrightHy Solutions, and BioSteam Energy platforms. With operations spanning LPG supply to hydrogen and bio-steam solutions, the Company supports decarbonization across industrial, residential, and commercial sectors. For more information, please visit www.fusion-fuel.eu.

Forward-Looking Statements

This press release and the statements contained herein include “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance. In some cases, you can identify these statements because they contain words such as “may,” “will,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” “plan,” “target,” “predict,” “potential,” or the negative of such terms, or other comparable terminology that concern the Company’s expectations, strategy, plans, or intentions. Forward-looking statements relating to expectations about future results or events are based upon information available to the Company as of today’s date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Such forward-looking statements include, but are not limited to, statements regarding: (i) the anticipated benefits of the leadership and Board changes announced herein, including the ability of the Company’s new Chairman and CEO to execute on the Company’s strategic direction; (ii) the Company’s contemplated acquisition of Royal Uranium and the expected benefits thereof, including expected royalty exposure to uranium exploration activity; (iii) the Company’s expectation to hold an investor update call and an Extraordinary General Meeting in connection with the Royal Uranium transaction; (iv) the Company’s strategic direction and growth plans, including with respect to its uranium royalty platform and energy commodity opportunities; and (v) statements regarding uranium market dynamics, including anticipated demand and supply trends. The Company’s expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the risk that the anticipated benefits of the leadership transition may not be realized; the risk that the Royal Uranium transaction may not be completed on the anticipated terms or timeline, or at all, including the risk that shareholder approval may not be obtained or that other closing conditions may not be satisfied; the Company’s ability to integrate Royal Uranium’s assets into its business, the ability of the parties to obtain Irish regulatory approval and any other required third-party consents and approvals in connection with the transaction, obtain the approval of the Company’s shareholders, and to meet all other closing conditions; the realization of revenues from the assets of Royal Uranium, including its royalties, which may depend on, among other things, the commercial development of uranium, the receipt and maintenance of exploration, mining, and environmental permits and approvals by the operators of the underlying properties, regulatory approval, and market demand for uranium; volatility in uranium and natural gas commodity prices, which directly affect the potential value of the anticipated royalty interests; the risk that operators of royalty-bearing properties may delay, suspend, or abandon exploration or development activities due to insufficient funding, unfavorable economic conditions, technical challenges, or regulatory obstacles; the possibility that exploration activities, including those authorized under recently obtained permits, may not result in the discovery of commercially viable mineral deposits or hydrocarbon reserves; the dependence of the Company on third-party operators over whom it has no operational control to generate revenues from the anticipated uranium and other royalty interests held by Royal Uranium, including decisions regarding the pace, scope, and method of exploration and development; the risk that changes in mining, environmental, or energy laws and regulations in the jurisdictions where the royalty assets are located, may adversely affect the feasibility or economics of the underlying projects; political, economic, and social risks associated with operating in foreign jurisdictions, including currency controls, expropriation, nationalization, and changes in fiscal regimes; the risk that royalty agreements may be subject to disputes regarding their scope, enforceability, or the calculation of permitted deductions from gross revenues; competition from existing or new offerings that may emerge; impacts from strategic changes to the Company’s business on net sales, revenues, income from continuing operations, or other results of operations; the Company’s ability to obtain sufficient funding to maintain operations and develop additional services and offerings; and the risks and uncertainties described under Item 3. “Key Information – D. Risk Factors” and elsewhere in the Company’s Annual Report on Form 20-F filed with the SEC on May 9, 2025, and other filings with the SEC. Should any of these risks or uncertainties materialize or should the underlying assumptions about the Company’s business and the commercial markets in which the Company operates prove incorrect, actual results may vary materially from those described as anticipated, estimated or expected. All subsequent written and oral forward-looking statements concerning the Company or other matters and attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. The Company does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof, except as required by law.

Investor Relations Contact:

[email protected]

www.fusion-fuel.eu

LOWELL, Mass., April 23, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI) plans to announce financial results for its second quarter ended April 3, 2026, before market open on Thursday, May 7, 2026. In conjunction with the release, MACOM will conduct a conference call at 8:30 a.m. Eastern Time on Thursday, May 7, 2026 hosted by Mr. Stephen G. Daly, President and Chief Executive Officer, and Mr. John F. Kober, Senior Vice President and Chief Financial Officer.

Please visit MACOM’s Investor Relations Website to register for a user-specific access code for the live call or to access the live webcast. A replay of the call will be available within 24 hours and remain accessible by all interested parties for approximately 90 days.

About MACOM
MACOM designs and manufactures high performance semiconductor products for the Industrial and Defense, Data Center and Telecommunications industries. MACOM services over 6,000 customers annually with a broad product portfolio that incorporates RF, Microwave, Analog and Mixed Signal and Optical semiconductor technologies. MACOM has achieved certification to the IATF16949 automotive standard, the AS9100D aerospace standard, the ISO9001 international quality standard and the ISO14001 environmental management standard. MACOM operates facilities across the United States, Europe, Asia and is headquartered in Lowell, Massachusetts. To learn more, please visit www.macom.com.

Company Contact:
MACOM Technology Solutions Holdings, Inc.
Stephen Ferranti, Senior Vice President, Corporate Development and Investor Relations
P: 978-656-2977
E: [email protected]

AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) — AINewsWire Editorial Coverage: Artificial intelligence is no longer confined to software innovation; it is increasingly becoming an energy-intensive phenomenon. As AI systems grow in size and sophistication, the computational requirements needed to train and run them are triggering a sharp rise in electricity consumption, one that is beginning to strain existing infrastructure. Data centers, once considered purely digital enablers, are now among the most power-demanding assets in the global economy. This evolution is prompting governments, utilities and private enterprises alike to reassess a critical constraint: the limiting factor in AI’s expansion may not be computing power but energy availability. Within this shifting landscape, American Fusion(TM) Inc. (OTC: AMFN) (profile) is positioning itself at the crossroads of advanced energy development and future infrastructure. By focusing on aneutronic fusion and the supporting supply chain, the company aims to develop scalable, efficient energy systems tailored to the needs of AI-driven workloads. Its strategy reflects a broader industry transition from theoretical exploration toward deployable energy solutions capable of sustaining long-term infrastructure demands. American Fusion operates alongside major players at the intersection of AI, energy demand and infrastructure, including NextEra Energy Inc. (NYSE: NEE), Duke Energy Corporation (NYSE: DUK), GE Vernova (NYSE: GEV) and Tesla Inc. (NASDAQ: TSLA).

• The expansion of AI is fueling a new phase of global data center growth, with electricity demand accelerating rapidly; American Fusion’s emphasis on scalable fusion energy aligns with these emerging market requirements.
• At the same time that demand is rising, existing power infrastructure is revealing its boundaries.
• While existing energy systems battle to maintain the pace, interest in next-generation energy technologies is increasing, with American Fusion playing an important part in this developing ecosystem.
• The company
  ’s approach focuses not just on reactor development but also on the broader ecosystem needed to sustain fusion energy.
• American Fusion exemplifies a wider industry transition by concentrating not only on advancing core technologies but also on establishing the operational foundation required to bring them to market.
  

Click here to view the custom infographic of the American Fusion editorial.

Rising AI Adoption Fuels Surging Electricity Needs

The expansion of artificial intelligence is fueling a new phase of global data center growth, with electricity demand accelerating rapidly. Projections indicate that data center power consumption could rise from approximately 448 terawatt-hours in 2025 to nearly 980 terawatt-hours by 2030, with AI-optimized servers accounting for roughly 44% of that increase.

This upward trend is driven by the computational intensity of modern AI systems, which rely on clusters of high-performance GPUs and specialized hardware operating continuously. As AI adoption spreads across industries, its energy footprint is becoming a central factor in infrastructure planning, marking a fundamental shift in how digital growth translates into physical resource demand.

Large-scale tech entities are leading this expansion. Organizations such as Microsoft, Google and Amazon are committing substantial capital to build out new data center capacity to support generative AI and cloud services. McKinsey & Company reports that generative AI could unlock between $2.6 trillion and $4.4 trillion in annual global economic value, but reaching those numbers will require substantial increases in both data center infrastructure and energy supply. This pressure is particularly visible in regions where hyperscale facilities are concentrated, as electricity demand begins to outpace existing grid capabilities.

Within this environment, American Fusion’s emphasis on scalable fusion energy aligns with emerging market requirements. By targeting continuous, high-efficiency power generation, the company is working toward solutions designed to support energy-intensive AI infrastructure. Its positioning reflects a growing recognition that future advances in computing will depend as much on energy access as on technological innovation.

Legacy Power Grids Face Mounting Strain

At the same time that demand is rising, existing power infrastructure is revealing its boundaries. Many electrical grids were built decades ago to serve predictable residential and industrial consumption patterns, not the concentrated, continuous demands of modern data centers. This imbalance is creating constraints that are slowing the rollout of new AI infrastructure.

These challenges are especially evident in fast-growing regions such as Texas. The Electric Reliability Council of Texas (ERCOT) has noted increasing load requirements, driven at least partially by industrial expansion and the rapid growth of data centers, with historical trends showing consistent upward pressure on the grid. As new facilities are built, electricity providers are finding it increasingly difficult to supply sufficient power without straining transmission systems.

As a result, project delays are more frequent. Some data center developments are being delayed due to insufficient grid capacity or the extended timelines required to expand transmission infrastructure. This dynamic creates a bottleneck where technological progress is limited not by innovation, but by the physical constraints of energy delivery systems.

American Fusion’s approach is designed to address this challenge by focusing on localized, high-output energy generation. When successfully implemented, fusion-based systems could reduce reliance on centralized grids by providing dedicated power sources for high-demand applications such as data centers. This model aligns with the growing need for flexible, scalable energy solutions that can be deployed closer to end users.

Next-Gen Energy Solutions Gain Traction

While existing energy systems battle to maintain the pace, interest in next-generation energy technologies is increasing. Nuclear fission, renewable energy and especially fusion are being discussed as viable solutions capable of delivering large-scale, reliable electricity without carbon emission issues that come with fossil fuels.

Fusion energy, often viewed as a theoretical development, is now advancing toward practical application. The U.S. Department of Energy explains fusion as the same process that powers the sun, providing potential for unlimited, carbon-free energy if it can be effectively controlled. The International Energy Agency also notes that fusion could be a meaningful component in future electricity systems as global demand continues to rise.

Significant global initiatives are already underway. Projects such as ITER signify large-scale international collaboration working to validate sustained fusion reactions at scale. At the same time, private-sector investment is moving upward as companies compete to bring fusion technologies to market.

American Fusion is an important piece of this developing ecosystem, with a focus on aneutronic fusion, a form of fusion that produces minimal neutron radiation and may offer advantages in both efficiency and safety. By developing both core technology and the infrastructure needed for full use, the company is operating within a space that is often viewed as essential to long-term energy solutions.

Fuel Availability, Supply Chains Present New Challenges

Even with its potential, fusion energy faces key obstacles, particularly related to fuel availability and infrastructure readiness. One of the most discussed issues is the supply of helium-3, a rare isotope considered a promising fuel for certain fusion reactions. The U.S. Department of Energy has identified helium-3 as a valuable resource for future energy systems, though its scarcity presents a significant obstacle.

The World Nuclear Association reports that while some fusion fuels, such as deuterium, are abundant, others, including helium and tritium, pose more difficult supply challenges that must be tackled before large-scale deployment can happen. These limitations underscore the importance of developing robust supply chains alongside technological innovation.

American Fusion’s approach reflects these issues by focusing not just on reactor development but also on the broader ecosystem needed to sustain fusion energy. These issues include fuel sourcing, logistics and long-term infrastructure planning, areas that are key as the industry moves closer to commercialization.

From Breakthroughs to Real-World Deployment

Fusion and advanced energy segments are transitioning from research-driven exploration to execution-focused development. As technologies are developed, attention is focused on building the substructure needed for large-scale deployment, such as manufacturing capabilities, supply chains and strategic partnerships.

McKinsey & Company has observed that while fusion has achieved meaningful technical progress, commercialization relies on the capability to scale production and incorporate processes and operations into current energy markets. Achieving this will require coordinated efforts across multiple disciplines, including engineering, materials science, policy and finance.

Collaboration is becoming a key driver of this evolution. Governments, research institutions and private companies are working together to fast-track development timelines and share resources. This collaboration is key to solving the technical and logistical obstacles that come with bringing new energy technologies to market.

American Fusion exemplifies this wider industry transition by concentrating not only on advancing core technologies but also on establishing the operational foundation required to bring them to market. The company’s focus on scalable implementation and supply chain development mirrors a broader movement within the sector toward execution-driven progress rather than purely experimental work. As energy supply increasingly becomes a gating factor for AI expansion, the ability to move from theoretical innovation to dependable, real-world deployment may ultimately separate leading companies from the rest.

Artificial intelligence is no longer influencing just the digital economy, it is actively reshaping the global energy framework as well. With computational demand rising at an accelerating pace, the pressure on power systems is intensifying, elevating energy infrastructure to a central constraint on future growth. Meeting this challenge will require more than incremental improvements, calling instead for coordinated advances in technology, significant capital investment in infrastructure and alignment across public and private sectors.

Within this shifting environment, organizations developing advanced energy solutions, especially those capable of producing efficient, scalable power, are taking on greater strategic importance. American Fusion’s role at the convergence of fusion innovation and infrastructure development reflects a larger industry pivot toward practical, deployment-ready systems. As AI adoption continues to expand, the capacity to consistently generate and distribute reliable electricity may become just as critical to progress as breakthroughs in the underlying algorithms

Powering the Energy Infrastructure Era

The rapid expansion of artificial intelligence and digital infrastructure is placing unprecedented demands on global energy systems, driving a new wave of investment in grid capacity, electrification and scalable power solutions. Across the industry, recent developments highlight how utilities, industrial technology providers and energy innovators are working to modernize transmission networks, expand access to renewable energy and deploy advanced systems designed to deliver reliable, high-capacity power for an increasingly electrified and data-driven economy.

NextEra Energy Inc.
(NYSE: NEE) has been recommended to deliver a critical energy infrastructure project by a regional grid operator. According to the company, PJM Interconnection has recommended NextEra Energy Transmission and Exelon to deliver the project as part of its Regional Transmission Expansion Plan. The approximately 220-mile 765-kilovolt (kV) high voltage transmission line is designed to support safe, reliable and affordable energy for families and communities across Pennsylvania and parts of West Virginia and spur significant economic growth. The transmission line would connect to substations that supply electricity to residents and businesses across the region. 

Duke Energy Corporation
(NYSE: DUK) reports that its newest clean-energy program for large business customers in North Carolina has surpassed initial enrollment targets. The company noted that the project, called Green Source Advantage Express (GSA Express), highlights the strong demand for flexible, streamlined access to renewable energy across the state. The voluntary program allows nonresidential customers to subscribe to capacity from new renewable energy facilities on Duke Energy’s grid, helping them match up to 100% of their annual electricity use without securing off-site generation on their own. Cisco, United States Cold Storage Inc. and Daimler Truck North America are among the first customers to participate in GSA Express.

GE Vernova
(NYSE: GEV) Power Conversion business has been awarded a contract by Singapore shipbuilder ST Engineering Marine Limited. The contract calls for the GE business to supply the shipbuilder’s Electric Grid with Integrated Full Electric Propulsion (IFEP) equipment for the Republic of Singapore Navy’s six-ship Multi-Role Combat Vessel (MRCV) program. The six MRCVs will be the first IFEP-powered vessels for the Republic of Singapore Navy (RSN) and will replace its fleet of mechanical drive Victory-class missile corvettes, which have been in service since 1989. Delivery of the electric propulsion systems for the new ships is planned over the next 10 years.

Tesla Inc.
(NASDAQ: TSLA) is working to build a sustainable, more resilient grid. As the demand for energy escalates, the company believes that the future of renewable energy relies on large-scale industrial energy storage. Tesla’s Megapack is a powerful, integrated battery system that provides clean, reliable, cost-effective energy storage to help stabilize the grid and prevent outages. “Reducing our reliance on fossil fuels and strengthening our grid infrastructure will make sustainable energy more accessible and affordable for everyone on Earth,” the company states.

These efforts underscore a broader convergence between energy infrastructure and next-generation technologies, where resilient grids and flexible power solutions are becoming essential to sustaining growth. As energy demand continues to rise alongside advances in AI and electrification, the ability to deliver efficient, scalable and sustainable power will remain a defining factor in supporting long-term innovation and economic development.

For more information, visit American Fusion.

About AINewsWire

AINewsWire
 (AINW) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

DISCLAIMER: AINewsWire (AINW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by AINW are solely those of AINW. Readers of this Article and content agree that they cannot and will not seek to hold liable AINW for any investment decisions by their readers or subscribers. AINW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, AINW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

AINW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AINW undertakes no obligation to update such statements.

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: 
https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
[email protected]
AINewsWire is powered by IBN